RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM

Translated title of the contribution: Adjuvant chemotherapy in breast cancer: Results and indications

K. W. Brunner, A. Goldhirsch, R. Joss, R. W. Sonntag, L. Tschopp

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

As the observation times of current studies using adjuvant chemotherapy in the treatment of operable stage II breast cancer lengthen, the probability of significantly reducing the high risk of developing metastases associated with this stage of the disease is also increasing and should be reflected in improved cure rates. The theoretical basis, prerequisites and presently available results for adjuvant chemotherapy of breast cancer are discussed. Adjuvant combination chemotherapy provides better results than monochemotherapy with Alkeran. While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance. Exact determination and documentation of the tumor stage, and especially the regional lymph node status, is the most important factor in determining the indication for adjuvant chemotherapy. Adjuvant chemotherapy is still beset with many unsolved problems. These include the duration, necessary intensity based upon risk factors, and short- and long-term side effects.

Original languageGerman
Pages (from-to)838-845
Number of pages8
JournalSchweizerische Medizinische Wochenschrift
Volume111
Issue number23
Publication statusPublished - 1981

Fingerprint

Adjuvant Chemotherapy
Breast Neoplasms
Melphalan
Combination Drug Therapy
Documentation
Lymph Nodes
Observation
Neoplasm Metastasis
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM. / Brunner, K. W.; Goldhirsch, A.; Joss, R.; Sonntag, R. W.; Tschopp, L.

In: Schweizerische Medizinische Wochenschrift, Vol. 111, No. 23, 1981, p. 838-845.

Research output: Contribution to journalArticle

Brunner, KW, Goldhirsch, A, Joss, R, Sonntag, RW & Tschopp, L 1981, 'RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM', Schweizerische Medizinische Wochenschrift, vol. 111, no. 23, pp. 838-845.
Brunner, K. W. ; Goldhirsch, A. ; Joss, R. ; Sonntag, R. W. ; Tschopp, L. / RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM. In: Schweizerische Medizinische Wochenschrift. 1981 ; Vol. 111, No. 23. pp. 838-845.
@article{d9271ca0e0744c1da232a9c83fd3b4ad,
title = "RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM",
abstract = "As the observation times of current studies using adjuvant chemotherapy in the treatment of operable stage II breast cancer lengthen, the probability of significantly reducing the high risk of developing metastases associated with this stage of the disease is also increasing and should be reflected in improved cure rates. The theoretical basis, prerequisites and presently available results for adjuvant chemotherapy of breast cancer are discussed. Adjuvant combination chemotherapy provides better results than monochemotherapy with Alkeran. While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance. Exact determination and documentation of the tumor stage, and especially the regional lymph node status, is the most important factor in determining the indication for adjuvant chemotherapy. Adjuvant chemotherapy is still beset with many unsolved problems. These include the duration, necessary intensity based upon risk factors, and short- and long-term side effects.",
author = "Brunner, {K. W.} and A. Goldhirsch and R. Joss and Sonntag, {R. W.} and L. Tschopp",
year = "1981",
language = "Tedesco",
volume = "111",
pages = "838--845",
journal = "Schweizerische Medizinische Wochenschrift",
issn = "0036-7672",
publisher = "EMH Swiss Medical Publishers Ltd.",
number = "23",

}

TY - JOUR

T1 - RESULTATE UND INDIKATIONEN DER ADJUVANTEN CHEMOTHERAPIE BEIM MAMMAKARZINOM

AU - Brunner, K. W.

AU - Goldhirsch, A.

AU - Joss, R.

AU - Sonntag, R. W.

AU - Tschopp, L.

PY - 1981

Y1 - 1981

N2 - As the observation times of current studies using adjuvant chemotherapy in the treatment of operable stage II breast cancer lengthen, the probability of significantly reducing the high risk of developing metastases associated with this stage of the disease is also increasing and should be reflected in improved cure rates. The theoretical basis, prerequisites and presently available results for adjuvant chemotherapy of breast cancer are discussed. Adjuvant combination chemotherapy provides better results than monochemotherapy with Alkeran. While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance. Exact determination and documentation of the tumor stage, and especially the regional lymph node status, is the most important factor in determining the indication for adjuvant chemotherapy. Adjuvant chemotherapy is still beset with many unsolved problems. These include the duration, necessary intensity based upon risk factors, and short- and long-term side effects.

AB - As the observation times of current studies using adjuvant chemotherapy in the treatment of operable stage II breast cancer lengthen, the probability of significantly reducing the high risk of developing metastases associated with this stage of the disease is also increasing and should be reflected in improved cure rates. The theoretical basis, prerequisites and presently available results for adjuvant chemotherapy of breast cancer are discussed. Adjuvant combination chemotherapy provides better results than monochemotherapy with Alkeran. While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance. Exact determination and documentation of the tumor stage, and especially the regional lymph node status, is the most important factor in determining the indication for adjuvant chemotherapy. Adjuvant chemotherapy is still beset with many unsolved problems. These include the duration, necessary intensity based upon risk factors, and short- and long-term side effects.

UR - http://www.scopus.com/inward/record.url?scp=0019512822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019512822&partnerID=8YFLogxK

M3 - Articolo

C2 - 7268339

AN - SCOPUS:0019512822

VL - 111

SP - 838

EP - 845

JO - Schweizerische Medizinische Wochenschrift

JF - Schweizerische Medizinische Wochenschrift

SN - 0036-7672

IS - 23

ER -